# Chemoradiation for Locally Advanced and Low Rectal Cancers: Avastin-Capecitabine-Oxaliplatin-Radiation REctal Cancer Trial

> **NCT00386828** · PHASE2 · COMPLETED · sponsor: **British Columbia Cancer Agency** · enrollment: 43 (actual)

## Conditions studied

- Advanced Colorectal Cancer

## Interventions

- **DRUG:** Bevacizumab:

## Key facts

- **NCT ID:** NCT00386828
- **Lead sponsor:** British Columbia Cancer Agency
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-10
- **Primary completion:** 2009-05
- **Final completion:** 2009-05
- **Target enrollment:** 43 (ACTUAL)
- **Last updated:** 2010-11-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00386828

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00386828, "Chemoradiation for Locally Advanced and Low Rectal Cancers: Avastin-Capecitabine-Oxaliplatin-Radiation REctal Cancer Trial". Retrieved via AI Analytics 2026-06-13 from https://api.ai-analytics.org/clinical/NCT00386828. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*